EdgarLookup

INSIGHT ENTERPRISES INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that INSIGHT ENTERPRISES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
1.9%
Profit Margin
Net income ÷ revenue
1.7%
Return on Assets
Net income ÷ assets
4.51x
Debt-to-Equity
Total liabilities ÷ equity
-5.2%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.25B Feb 12, 2026
FY2025 Dec 31, 2024 $8.70B Feb 12, 2026
FY2025 Dec 31, 2023 $9.18B Feb 12, 2026
FY2024 Dec 31, 2022 $10.43B Feb 14, 2025
FY2023 Dec 31, 2021 $9.44B Feb 22, 2024
FY2020 Dec 31, 2020 $2.29B Feb 17, 2021
FY2020 Sep 30, 2020 $1.94B Feb 17, 2021
FY2020 Jun 30, 2020 $1.97B Feb 17, 2021
FY2020 Mar 31, 2020 $2.14B Feb 17, 2021
FY2020 Dec 31, 2019 $2.30B Feb 17, 2021

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $1.78B Feb 26, 2018
FY2017 Sep 30, 2017 $1.76B Feb 26, 2018
FY2017 Jun 30, 2017 $1.68B Feb 26, 2018
FY2017 Mar 31, 2017 $1.48B Feb 26, 2018
FY2017 Dec 31, 2016 $1.47B Feb 26, 2018
FY2017 Sep 30, 2016 $1.39B Feb 26, 2018
FY2017 Jun 30, 2016 $1.46B Feb 26, 2018
FY2017 Mar 31, 2016 $1.17B Feb 26, 2018
FY2016 Dec 31, 2015 $1.39B Feb 17, 2017
FY2016 Sep 30, 2015 $1.34B Feb 17, 2017

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.76B Feb 12, 2026
FY2025 Dec 31, 2024 $1.77B Feb 12, 2026
FY2025 Dec 31, 2023 $1.67B Feb 12, 2026
FY2024 Dec 31, 2022 $1.64B Feb 14, 2025
FY2023 Dec 31, 2021 $1.45B Feb 22, 2024
FY2020 Dec 31, 2020 $342.65M Feb 17, 2021
FY2020 Sep 30, 2020 $307.56M Feb 17, 2021
FY2020 Jun 30, 2020 $324.39M Feb 17, 2021
FY2020 Mar 31, 2020 $325.34M Feb 17, 2021
FY2020 Dec 31, 2019 $337.98M Feb 17, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $157.35M Feb 12, 2026
FY2025 Dec 31, 2024 $249.69M Feb 12, 2026
FY2025 Dec 31, 2023 $281.31M Feb 12, 2026
FY2024 Dec 31, 2022 $280.61M Feb 14, 2025
FY2023 Dec 31, 2021 $219.35M Feb 22, 2024
FY2020 Dec 31, 2020 $53.39M Feb 17, 2021
FY2020 Sep 30, 2020 $38.91M Feb 17, 2021
FY2020 Jun 30, 2020 $46.39M Feb 17, 2021
FY2020 Mar 31, 2020 $33.96M Feb 17, 2021
FY2020 Dec 31, 2019 $42.95M Feb 17, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $334.92M Feb 12, 2026
FY2025 Dec 31, 2024 $388.58M Feb 12, 2026
FY2025 Dec 31, 2023 $419.80M Feb 12, 2026
FY2024 Dec 31, 2022 $413.70M Feb 14, 2025
FY2023 Dec 31, 2021 $332.06M Feb 22, 2024
FY2020 Dec 31, 2020 $83.04M Feb 17, 2021
FY2020 Sep 30, 2020 $61.48M Feb 17, 2021
FY2020 Jun 30, 2020 $74.19M Feb 17, 2021
FY2020 Mar 31, 2020 $52.86M Feb 17, 2021
FY2020 Dec 31, 2019 $67.02M Feb 17, 2021

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.39B Feb 12, 2026
FY2025 Dec 31, 2024 $1.34B Feb 12, 2026
FY2025 Dec 31, 2023 $1.24B Feb 12, 2026
FY2024 Dec 31, 2022 $1.22B Feb 14, 2025
FY2023 Dec 31, 2021 $1.12B Feb 22, 2024
FY2020 Dec 31, 2020 $257.17M Feb 17, 2021
FY2020 Sep 30, 2020 $245.16M Feb 17, 2021
FY2020 Jun 30, 2020 $242.58M Feb 17, 2021
FY2020 Mar 31, 2020 $268.86M Feb 17, 2021
FY2020 Dec 31, 2019 $266.97M Feb 17, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $303.83M Feb 12, 2026
FY2025 Dec 31, 2024 $632.85M Feb 12, 2026
FY2025 Dec 31, 2023 $619.53M Feb 12, 2026
FY2024 Dec 31, 2022 $98.11M Feb 14, 2025
FY2023 Dec 31, 2021 $163.71M Feb 22, 2024
FY2022 Dec 31, 2020 $355.58M Feb 16, 2023
FY2021 Dec 31, 2019 $127.88M Feb 18, 2022
FY2020 Dec 31, 2018 $292.65M Feb 17, 2021
FY2019 Dec 31, 2017 ($307.07M) Feb 21, 2020
FY2018 Dec 31, 2016 $96.08M Feb 22, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $24.52M Feb 12, 2026
FY2025 Dec 31, 2024 $46.78M Feb 12, 2026
FY2025 Dec 31, 2023 $39.25M Feb 12, 2026
FY2024 Dec 31, 2022 $70.94M Feb 14, 2025
FY2023 Dec 31, 2021 $52.08M Feb 22, 2024
FY2022 Dec 31, 2020 $24.18M Feb 16, 2023
FY2021 Dec 31, 2019 $69.09M Feb 18, 2022
FY2020 Dec 31, 2018 $17.25M Feb 17, 2021
FY2019 Dec 31, 2017 $19.23M Feb 21, 2020
FY2018 Dec 31, 2016 $12.27M Feb 22, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.09B Feb 12, 2026
FY2025 Dec 31, 2024 $7.45B Feb 12, 2026
FY2024 Dec 31, 2023 $6.29B Feb 14, 2025
FY2023 Dec 31, 2022 $5.11B Feb 22, 2024
FY2022 Dec 31, 2021 $4.69B Feb 16, 2023
FY2021 Dec 31, 2020 $4.31B Feb 18, 2022
FY2020 Dec 31, 2019 $4.18B Feb 17, 2021
FY2019 Dec 31, 2018 $2.78B Feb 21, 2020
FY2018 Dec 31, 2017 $2.69B Feb 22, 2019
FY2017 Dec 31, 2016 $2.22B Feb 26, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.44B Feb 12, 2026
FY2025 Dec 31, 2024 $5.68B Feb 12, 2026
FY2024 Dec 31, 2023 $4.55B Feb 14, 2025
FY2023 Dec 31, 2022 $3.47B Feb 22, 2024
FY2022 Dec 31, 2021 $3.18B Feb 16, 2023
FY2021 Dec 31, 2020 $2.97B Feb 18, 2022
FY2020 Dec 31, 2019 $3.02B Feb 17, 2021
FY2019 Dec 31, 2018 $1.79B Feb 21, 2020
FY2018 Dec 31, 2017 $1.84B Feb 22, 2019
FY2017 Dec 31, 2016 $1.51B Feb 26, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.65B Feb 12, 2026
FY2025 Dec 31, 2024 $1.77B Feb 12, 2026
FY2025 Dec 31, 2023 $1.74B Feb 12, 2026
FY2025 Dec 31, 2022 $1.64B Feb 12, 2026
FY2024 Dec 31, 2021 $1.51B Feb 14, 2025
FY2023 Dec 31, 2020 $1.34B Feb 22, 2024
FY2022 Dec 31, 2019 $1.16B Feb 16, 2023
FY2021 Dec 31, 2018 $986.99M Feb 18, 2022
FY2020 Dec 31, 2017 $843.47M Feb 17, 2021
FY2019 Dec 31, 2016 $713.44M Feb 21, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.17B Feb 12, 2026
FY2025 Dec 31, 2024 $893.52M Feb 12, 2026
FY2025 Dec 31, 2023 $684.35M Feb 12, 2026
FY2023 Dec 31, 2022 $493.03M Feb 22, 2024
FY2022 Dec 31, 2021 $428.35M Feb 16, 2023
FY2021 Dec 31, 2020 $429.37M Feb 18, 2022
FY2020 Dec 31, 2019 $415.15M Feb 17, 2021
FY2019 Dec 31, 2018 $166.84M Feb 21, 2020
FY2018 Dec 31, 2017 $131.43M Feb 22, 2019
FY2017 Dec 31, 2016 $62.65M Feb 26, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.52B Feb 12, 2026
FY2025 Dec 31, 2024 $1.51B Feb 12, 2026
FY2024 Dec 31, 2023 $1.45B Feb 14, 2025
FY2023 Dec 31, 2022 $1.37B Feb 22, 2024
FY2022 Dec 31, 2021 $1.17B Feb 16, 2023
FY2021 Dec 31, 2020 $993.25M Feb 18, 2022
FY2020 Dec 31, 2019 $841.10M Feb 17, 2021
FY2019 Dec 31, 2018 $704.67M Feb 21, 2020
FY2018 Dec 31, 2017 $550.22M Feb 22, 2019
FY2017 Dec 31, 2016 $459.54M Feb 26, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $358.02M Feb 12, 2026
FY2025 Dec 31, 2024 $259.23M Feb 12, 2026
FY2024 Dec 31, 2023 $268.73M Feb 14, 2025
FY2023 Dec 31, 2022 $163.64M Feb 22, 2024
FY2022 Dec 31, 2021 $103.84M Feb 16, 2023
FY2021 Dec 31, 2020 $128.31M Feb 18, 2022
FY2020 Dec 31, 2019 $114.67M Feb 17, 2021
FY2019 Dec 31, 2018 $142.66M Feb 21, 2020
FY2018 Dec 31, 2017 $105.83M Feb 22, 2019
FY2018 Dec 31, 2016 $202.88M Feb 22, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2014 Dec 31, 2014 $61.00M Feb 20, 2015

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 5 Feb 12, 2026
FY2025 Dec 31, 2024 7 Feb 12, 2026
FY2025 Dec 31, 2023 8 Feb 12, 2026
FY2022 Dec 31, 2022 2 Feb 16, 2023
FY2023 Dec 31, 2021 6 Feb 22, 2024
FY2020 Dec 31, 2020 1 Feb 17, 2021
FY2020 Sep 30, 2020 1 Feb 17, 2021
FY2020 Jun 30, 2020 1 Feb 17, 2021
FY2020 Mar 31, 2020 0 Feb 17, 2021
FY2020 Dec 31, 2019 1 Feb 17, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 4 Feb 12, 2026
FY2025 Dec 31, 2024 6 Feb 12, 2026
FY2025 Dec 31, 2023 7 Feb 12, 2026
FY2022 Dec 31, 2022 2 Feb 16, 2023
FY2023 Dec 31, 2021 5 Feb 22, 2024
FY2020 Dec 31, 2020 1 Feb 17, 2021
FY2020 Sep 30, 2020 1 Feb 17, 2021
FY2020 Jun 30, 2020 1 Feb 17, 2021
FY2020 Mar 31, 2020 0 Feb 17, 2021
FY2020 Dec 31, 2019 1 Feb 17, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 31.00M Feb 12, 2026
FY2025 Dec 31, 2024 31.78M Feb 12, 2026
FY2024 Dec 31, 2023 32.59M Feb 14, 2025
FY2023 Dec 31, 2022 34.01M Feb 22, 2024
FY2022 Dec 31, 2021 34.90M Feb 16, 2023
FY2021 Dec 31, 2020 35.10M Feb 18, 2022
FY2020 Dec 31, 2019 35.26M Feb 17, 2021
FY2019 Dec 31, 2018 35.48M Feb 21, 2020
FY2018 Dec 31, 2017 35.83M Feb 22, 2019
FY2017 Dec 31, 2016 35.48M Feb 26, 2018